How much profit has Ipsen made this year?
Ipsen has made 758.24 M EUR this year.
Ipsen Net Income 2024
Ipsen Net Income
758.24 M EUR
Ipsen Dividend yield
1.01 %
Ticker
IPN.PA
ISIN
FR0010259150
WKN
A0ESMG
In 2024, Ipsen's profit amounted to 758.24 M EUR, a 17.67% increase from the 644.4 M EUR profit recorded in the previous year.
The Ipsen Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2029e | 847.03 |
| 2028e | 981.15 |
| 2027e | 985.98 |
| 2026e | 895.54 |
| 2025e | 824.71 |
| 2024e | 758.24 |
| 2023 | 644.4 |
| 2022 | 648.6 |
| 2021 | 646.6 |
| 2020 | 548 |
| 2019 | -50.7 |
| 2018 | 389.5 |
| 2017 | 272.3 |
| 2016 | 225.9 |
| 2015 | 189.9 |
| 2014 | 153.5 |
| 2013 | 152.5 |
| 2012 | -27.93 |
| 2011 | 0.42 |
| 2010 | 95.27 |
| 2009 | 156.58 |
| 2008 | 146.56 |
| 2007 | 150.61 |
| 2006 | 144.01 |
| 2005 | 119.23 |
| 2004 | 83 |
Ipsen Aktienanalyse
What does Ipsen do?
Ipsen SA is a French biopharmaceutical company specialized in the development of drugs for the treatment of cancer, neurological disorders, and endocrine disorders. It was founded in 1929 by a pharmacist named Henri Beaufour and is headquartered in Paris. The history of Ipsen began with the production of extraction products from snake venom for the manufacturing of serum against tetanus and diphtheria. In the 1960s, the company started to focus on the production of hormones and peptides, with a focus on endocrine disorders. In the 1990s, Ipsen expanded its product portfolio to include oncology and neurological disorders. Ipsen's business model focuses on research and development of new drugs, as well as marketing of already established drugs in selected markets worldwide. The company employs around 5,700 employees and operates in more than 115 countries. Ipsen has two main business segments: specialty drugs and consumer healthcare. The specialty drugs segment focuses on the development and marketing of innovative therapies in the areas of oncology, endocrinology, and neuroscience. Ipsen's most well-known products include Somatuline, a drug for the treatment of acromegaly, and Decapeptyl, a drug for the treatment of prostate cancer and endometriosis. In the consumer healthcare segment, Ipsen is mainly specialized in the production of drugs for the treatment of gastrointestinal disorders and cold and flu symptoms. Some well-known brands include Smecta, a drug for diarrhea, and Nurofen, a pain reliever. Ipsen also has a strong presence in the field of aesthetic medicine, where the company operates a subsidiary called Ipsen Aesthetic. This subsidiary develops and markets products for the treatment of wrinkles and other signs of aging on the skin. Well-known brands of Ipsen Aesthetic include Dysport, a botulinum toxin product for the treatment of wrinkles, and the filler Restylane. Overall, Ipsen has established itself as a leading biopharmaceutical company focused on the development and marketing of products in specialized therapy areas. The company has a strong pipeline of new products in development and remains an important player in the pharmaceutical industry due to its strong scientific expertise and global presence. Ipsen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Ipsen's Profit Margins
The profit margins of Ipsen represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Ipsen's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Ipsen's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Ipsen's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Ipsen’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Ipsen Stock
How has the profit developed compared to last year?
The profit has increased by 17.67% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Ipsen publish its earnings?
Ipsen publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Ipsen?
The profits of Ipsen are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Ipsen?
You can learn more about the earnings of Ipsen by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Ipsen pay?
Over the past 12 months, Ipsen paid a dividend of 1.2 EUR . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Ipsen is expected to pay a dividend of 1.4 EUR.
What is the dividend yield of Ipsen?
The current dividend yield of Ipsen is 1.01 %.
When does Ipsen pay dividends?
Ipsen pays a quarterly dividend. This is distributed in the months of June, June, July, June.
How secure is the dividend of Ipsen?
Ipsen paid dividends every year for the past 24 years.
What is the dividend of Ipsen?
For the upcoming 12 months, dividends amounting to 1.4 EUR are expected. This corresponds to a dividend yield of 1.18 %.
In which sector is Ipsen located?
Ipsen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ipsen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ipsen from 6/3/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.
When did Ipsen pay the last dividend?
The last dividend was paid out on 6/3/2024.
What was the dividend of Ipsen in the year 2023?
In the year 2023, Ipsen distributed 1.2 EUR as dividends.
In which currency does Ipsen pay out the dividend?
The dividends of Ipsen are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ipsen stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ipsen
Our stock analysis for Ipsen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ipsen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
